880126 | DSPE-PEG(2000) Maleimide

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] (ammonium salt)


Chloroform

Size SKU Packaging Price
25mg 880126C-25mg 880126C-25mg 1 x 25mg 10mg/mL 2.5mL $333.75
50mg 880126C-50mg 880126C-50mg 1 x 50mg 25mg/mL 2mL $577.00
100mg 880126C-100mg 880126C-100mg 1 x 100mg 25mg/mL 4mL $1,057.00

Powder

Size SKU Packaging Price
10mg 880126P-10mg 880126P-10mg 1 x 10mg $175.50
25mg 880126P-25mg 880126P-25mg 1 x 25mg $333.75
50mg 880126P-50mg 880126P-50mg 1 x 50mg $577.00
100mg 880126P-100mg 880126P-100mg 1 x 100mg $1,057.00
500mg 880126P-500mg 880126P-500mg 1 x 500mg $4,020.00
Base Price: ${originalprice|money}
Custom Packaging: (${concentration} @$4.00/ea. + $100) ${custompackagingtotal|money}
Packaging: ${concentration}
Item Total: ${totalprice|money}
(Sales Tax may apply)
Please select an option above.
${sku} - ${concentration}

DSPE-PEG(2000) Maleimide

DSPE-PEG(2000) Maleimide

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] (ammonium salt)

Representative Structure

The molecular weight and exact mass are averages based on the polydispersity of PEG. 

Hygroscopic
Yes
Light Sensitive
No
Molecular Formula

C139H271N4O57P (average MW due to polydispersity of PEG)

Percent Composition

C 56.76%, H 9.29%, N 1.90%, O 31.00%, P 1.05%

Purity
>99%
Stability
1 Year
Storage Temperature
-20°C
CAS Number
474922-22-0
CAS Registry Number is a Registered Trademark of the American Chemical Society
Formula Weight
2941.642
Exact Mass
2939.817

Bao Y, Hu Q, Wang X, Feng X, He Y, Guo Y, Fu D. Chemo-immunotherapy with doxorubicin prodrug and erythrocyte membrane-enveloped polymer nano-vaccine enhances antitumor activity. Biomed Pharmacother. 2020 Jun 15;129:110377. doi: 10.1016/j.biopha.2020.110377. Epub ahead of print. PMID: 32554247.

PubMed ID: 32554247

Cerroni B, Riva FR, Oddo L, Domenici F, Tortorella E, Toumia Y, Brasili F, Paradossi G. In vitro analysis of the trajectories of adhesive microbubbles approaching endothelial cells. J Colloid Interface Sci. 2020 Jun 5;578:758-767. doi: 10.1016/j.jcis.2020.06.009. Epub ahead of print. PMID: 32574909.

PubMed ID: 32574909

Kim CH, Kang TH, Kim BD, Lee TH, Yoon HY, Goo YT, Choi YS, Kang MJ, Choi YW. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells. Int J Pharm. 2020 Jun 15;583:119393. doi: 10.1016/j.ijpharm.2020.119393. Epub 2020 May 4. PMID: 32376445.

PubMed ID: 32376445

Bohley MS, Birch E, Baumann FJ, Dillinger AE, Tamm ER, Goepferich AM. Design of dye and superparamagnetic iron oxide nanoparticle loaded lipid nanocapsules with dual detectability in vitro and in vivo. Int J Pharm. 2020 May 21;585:119433. doi: 10.1016/j.ijpharm.2020.119433. Epub ahead of print. PMID: 32447023.

PubMed ID: 32447023

Qin YE, Tang WF, Xu Y, Wan FR, Chen AH. Ultrasound-Mediated Co-Delivery of miR-34a and sPD-1 Complexed with Microbubbles for Synergistic Cancer Therapy. Cancer Manag Res. 2020 Apr 5;12:2459-2469. doi: 10.2147/CMAR.S238643. PMID: 32308482; PMCID: PMC7148163.

PubMed ID: 32308482

Nasery MM, Eslaminejad T, Mandeghary A, Zeinali M, Pardakhti A, Behnam B, Mohammadi M. Cytotoxicity Evaluation of Curcumin-Loaded Affibody-Decorated Liposomes against Breast Cancerous Cell Lines. J Liposome Res. 2020 Apr 15:1-20. doi: 10.1080/08982104.2020.1755981. Epub ahead of print. PMID: 32292087.

PubMed ID: 32292087

Zamani P, Navashenaq JG, Teymouri M, Karimi M, Mashreghi M, Jaafari MR. Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sci. 2020 Jul 1;252:117646. doi: 10.1016/j.lfs.2020.117646. Epub 2020 Apr 7. PMID: 32272178.

PubMed ID: 32272178

Han Y, Chu X, Cui L, Fu S, Gao C, Li Y, Sun B. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Deliv. 2020 Dec;27(1):502-518. doi: 10.1080/10717544.2020.1745328. PMID: 32228100; PMCID: PMC7170363.

PubMed ID: 32228100

Lee H, Jiang D, Pardridge WM. Lyoprotectant Optimization for the Freeze-Drying of Receptor-Targeted Trojan Horse Liposomes for Plasmid DNA Delivery. Mol Pharm. 2020 Apr 29. doi: 10.1021/acs.molpharmaceut.0c00310. Epub ahead of print. PMID: 32315188.

PubMed ID: 32315188

Harmon JS, Celingant-Copie CA, Kabinejadian F, Bull J. Lipid shell retention and selective binding capability following repeated transient acoustic microdroplet vaporization. Langmuir. 2020 May 18. doi: 10.1021/acs.langmuir.0c00320. Epub ahead of print. PMID: 32420747.

PubMed ID: 32420747

Gao C, Wang Y, Sun J, Han Y, Gong W, Li Y, Feng Y, Wang H, Yang M, Li Z, Yang Y, Gao C. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice. Acta Biomater. 2020 May;108:285-299. doi: 10.1016/j.actbio.2020.03.029. Epub 2020 Apr 3. PMID: 32251785.

PubMed ID: 32251785

Zamani P, Teymouri M, Nikpoor AR, Navashenaq JG, Gholizadeh Z, Darban SA, Jaafari MR. Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. Eur J Cancer. 2020 Apr;129:80-96. doi: 10.1016/j.ejca.2020.01.010. Epub 2020 Mar 4. PMID: 32145473.

PubMed ID: 32145473

Omersa N, Aden S, Kisovec M, Podobnik M, Anderluh G. Design of Protein Logic Gate System Operating on Lipid Membranes. ACS Synth Biol. 2020 Feb 21;9(2):316-328. doi: 10.1021/acssynbio.9b00340. Epub 2020 Feb 11. PMID: 31995709.

PubMed ID: 31995709

Li M, Li M, Yang Y, Liu Y, Xie H, Yu Q, Tian L, Tang X, Ren K, Li J, Zhang Z, He Q. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. J Control Release. 2020 Feb 5;321:23-35. doi: 10.1016/j.jconrel.2020.02.011. Epub ahead of print. PMID: 32035193.

PubMed ID: 32035193

Farell M, Self A, Guza C, Song H, Apollon L, Gomez EW, Kumar M. Lipid-Functionalized Graphene Loaded with hMnSOD for Selective Inhibition of Cancer Cells. ACS Appl Mater Interfaces. 2020 Mar 18;12(11):12407-12416. doi: 10.1021/acsami.9b20070. Epub 2020 Mar 6. PMID: 32077682.

PubMed ID: 32077682

Ramishetti S, Hazan-Halevy I, Palakuri R, Chatterjee S, Naidu Gonna S, Dammes N, Freilich I, Kolik Shmuel L, Danino D, Peer D. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes. Adv Mater. 2020 Jan 30:e1906128. doi: 10.1002/adma.201906128. Epub ahead of print. PMID: 31999380.

PubMed ID: 31999380

Asadpour O, Rahbarizadeh F. Phospholipase-Cγ1 Signaling Protein Down-Regulation by Oligoclonal-VHHs based Immuno-Liposome: A Potent Metastasis Deterrent in HER2 Positive Breast Cancer Cells. Cell J. 2020 Apr;22(1):30-39. doi: 10.22074/cellj.2020.6704. Epub 2019 Sep 8. PMID: 31606964; PMCID: PMC6791071.

PubMed ID: 31606964

Asasutjarit R, Managit C, Phanaksri T, Treesuppharat W, Fuongfuchat A. Formulation development and in vitro evaluation of transferrin-conjugated liposomes as a carrier of ganciclovir targeting the retina. Int J Pharm. 2020 Jan 25;577:119084. doi: 10.1016/j.ijpharm.2020.119084. Epub ahead of print. PMID: 31988033.

PubMed ID: 31988033

Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, Lin CY, Lin YC, Chang PC, Lin SY, Chen Y. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Sci Adv. 2020 Jan 15;6(3):eaax5032. doi: 10.1126/sciadv.aax5032. PMID: 31998834; PMCID: PMC6962042.

PubMed ID: 31998834

Yoon HY, Yang HM, Kim CH, Goo YT, Hwang GY, Chang IH, Whang YM, Choi YW. Enhanced Intracellular Delivery of BCG Cell Wall Skeleton into Bladder Cancer Cells Using Liposomes Functionalized with Folic Acid and Pep-1 Peptide. Pharmaceutics. 2019 Dec 4;11(12):E652. doi: 10.3390/pharmaceutics11120652. PMID: 31817179.

PubMed ID: 31817179

Lee JY, Shin DH, Kim JS. Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer. Pharmaceutics. 2019 Dec 20;12(1):E11. doi: 10.3390/pharmaceutics12010011. PMID: 31877620.

PubMed ID: 31877620

Thapa RK, Kiick KL, Sullivan MO. Encapsulation of collagen mimetic peptide-tethered vancomycin liposomes in collagen-based scaffolds for infection control in wounds. Acta Biomater. 2019 Dec 13;S1742-7061(19)30843-8. doi: 10.1016/j.actbio.2019.12.014. [Epub ahead of print]. PMID: 31843720.

PubMed ID: 31843720

Norouz Dizaji A, Ding D, Kutsal T, Turk M, Kong D, Piskin E. In vivo imaging/detection of MRSA bacterial infections in mice using fluorescence labelled polymeric nanoparticles carrying vancomycin as the targeting agent. J Biomater Sci Polym Ed. 2019 Nov 25:1-17. doi: 10.1080/09205063.2019.1692631. [Epub ahead of print]

PubMed ID: 31762403

Yeow YL, Kotamraju VR, Wang X, Chopra M, Azme N, Wu J, Schoep TD, Delaney DS, Feindel K, Li J, Kennedy KM, Allen WM, Kennedy BF, Larma I, Sampson DD, Mahakian LM, Fite BZ, Zhang H, Friman T, Mann AP, Aziz FA, Kumarasinghe MP, Johansson M, Ee HC, Yeoh G, Mou L, Ferrara KW, Billiran H, Ganss R, Ruoslahti E, Hamzah J. Immune-mediated ECM depletion improves tumour perfusion and payload delivery. EMBO Mol Med. 2019 Dec;11(12):e10923. doi: 10.15252/emmm.201910923. Epub 2019 Nov 11.

PubMed ID: 31709774

Qu F, Wang P, Zhang K, Shi Y, Li Y, Li C, Lu J, Liu Q, Wang X. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy. Autophagy. 2019 Nov 9:1-23. doi: 10.1080/15548627.2019.1687210. [Epub ahead of print]

PubMed ID: 31674265

Zheng Z, Ji H, Zong W, Ran Q, Wang X, Yang X, Zhao Z, Yang C, Xiao Y. Construction and characterization of immunoliposomes targeting fibroblast growth factor receptor 3. AMB Express. 2019 Sep 18;9(1):150. doi: 10.1186/s13568-019-0875-5.

PubMed ID: 31535232

Ou W, Jiang L, Gu Y, Soe ZC, Kim BK, Gautam M, Poudel K, Pham LM, Phung CD, Chang JH, Kim JR, Ku SK, Yong CS, Kim JO. Regulatory T Cells Tailored with pH-Responsive Liposomes Shape an Immuno-Antitumor Milieu against Tumors. ACS Appl Mater Interfaces. 2019 Oct 9;11(40):36333-36346. doi: 10.1021/acsami.9b11371. Epub 2019 Sep 27.

PubMed ID: 31535550

Oddo L, Paradossi G, Cerroni B, Ben-Harush C, Ariel E, Di Meco F, Ram Z, Grossman R. In Vivo Biodistribution of Engineered Lipid Microbubbles in Rodents. ACS Omega. 2019 Aug 8;4(8):13371-13381. doi: 10.1021/acsomega.9b01544. eCollection 2019 Aug 20.

PubMed ID: 31460465

Wang Z, Zhao K, Zhang Y, Duan X, Zhao Y. Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers. Pharm Res. 2019 Aug 8;36(10):145. doi: 10.1007/s11095-019-2669-5.

PubMed ID: 31396764

Fuior EV, Deleanu M, Constantinescu CA, Rebleanu D, Voicu G, Simionescu M, Calin M. Functional Role of VCAM-1 Targeted Flavonoid-Loaded Lipid Nanoemulsions in Reducing Endothelium Inflammation. Pharmaceutics. 2019 Aug 3;11(8). pii: E391. doi: 10.3390/pharmaceutics11080391.

PubMed ID: 31382634

Shi D, Mi G, Shen Y, Webster TJ. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier. Nanoscale. 2019 Aug 15;11(32):15057-15071. doi: 10.1039/c9nr03931g.

PubMed ID: 31369016

Sun S, Zou H, Li L, Liu Q, Ding N, Zeng L, Li H, Mao S. CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape. Int J Pharm. 2019 Sep 10;568:118518. doi: 10.1016/j.ijpharm.2019.118518. Epub 2019 Jul 15.

PubMed ID: 31319147

Nik ME, Malaekeh-Nikouei B, Amin M, Hatamipour M, Teymouri M, Sadeghnia HR, Iranshahi M, Jaafari MR. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma. Sci Rep. 2019 Jul 2;9(1):9527. doi: 10.1038/s41598-019-45974-7.

PubMed ID: 31267009

Wang F, Sun Y, Shi J. Programmed death-ligand 1 monoclonal antibody-linked immunoliposomes for synergistic efficacy of miR-130a and oxaliplatin in gastric cancers. Nanomedicine (Lond). 2019 Jul;14(13):1729-1744. doi: 10.2217/nnm-2019-0073. Epub 2019 Jul 10.

PubMed ID: 31290727

Witzigmann D, Uhl P, Sieber S, Kaufman C, Einfalt T, Schöneweis K, Grossen P, Buck J, Ni Y, Schenk SH, Hussner J, Meyer Zu Schwabedissen HE, Québatte G, Mier W, Urban S, Huwyler J. Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide. Elife. 2019 Jul 23;8. pii: e42276. doi: 10.7554/eLife.42276.

PubMed ID: 31333191

Yang X, Zhao J, Duan S, Hou X, Li X, Hu Z, Tang Z, Mo F, Lu X. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers. Theranostics. 2019 May 31;9(14):4066-4083. doi: 10.7150/thno.33383. eCollection 2019.

PubMed ID: 31281532

Camara M, Cournoyer M, Sadiki M, Martin N. Characterization and Removal of Buddy Off-Flavor in Maple Syrup. J Food Sci. 2019 Jun;84(6):1538-1546. doi: 10.1111/1750-3841.14618. Epub 2019 May 23.

PubMed ID: 31220572

Yan Y, Li XQ, Duan JL, Bao CJ, Cui YN, Su ZB, Xu JR, Luo Q, Chen M, Xie Y, Lu WL. Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene. Int J Nanomedicine. 2019 May 17;14:3645-3667. doi: 10.2147/IJN.S207837. eCollection 2019.

PubMed ID: 31190817

Kristensen K, Engel TB, Stensballe A, Simonsen JB, Andresen TL. The hard protein corona of stealth liposomes is sparse. J Control Release. 2019 Jun 3;307:1-15. doi: 10.1016/j.jconrel.2019.05.042. [Epub ahead of print]

PubMed ID: 31170467

Huang Y, Huang Y, He J, Wang H, Luo Y, Li Y, Liu J, Zhong L, Zhao Y. PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene. Biomaterials. 2019 Oct;217:119231. doi: 10.1016/j.biomaterials.2019.119231. Epub 2019 Jun 14.

PubMed ID: 31254933

Marazioti A, Papadia K, Kannavou M, Spella M, Basta A, de Lastic AL, Rodi M, Mouzaki A, Samiotaki M, Panayotou G, Stathopoulos GT, Antimisiaris SG. Cellular Vesicles: New insights in engineering methods, interaction with cells and potential for brain targeting. J Pharmacol Exp Ther. 2019 May 6. pii: jpet.119.257097. doi: 10.1124/jpet.119.257097. [Epub ahead of print]

PubMed ID: 31061141

Zhao Z, Hu Y, Harmon T, Pentel P, Ehrich M, Zhang C. Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine. Mol Pharm. 2019 Jun 3;16(6):2766-2775. doi: 10.1021/acs.molpharmaceut.9b00279. Epub 2019 May 22.

PubMed ID: 31075204

Guo X, Dong C, Liu Q, Zhu X, Zuo S, Zhang H. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres. Biomed Pharmacother. 2019 Jun;114:108823. doi: 10.1016/j.biopha.2019.108823. Epub 2019 Apr 6.

PubMed ID: 30965238

Gholamian Dehkordi N, Elahian F, Khosravian P, Mirzaei SA. Intelligent TAT-coupled anti-HER2 immunoliposomes knock downed MDR1 to produce chemosensitize phenotype of multidrug resistant carcinoma. J Cell Physiol. 2019 Apr 18. doi: 10.1002/jcp.28683. [Epub ahead of print]

PubMed ID: 31001890

Saeed M, Zalba S, Seynhaeve ALB, Debets R, Ten Hagen TLM. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. Int J Nanomedicine. 2019 Mar 26;14:2069-2089. doi: 10.2147/IJN.S190736. eCollection 2019.

PubMed ID: 30988609

Hua S, Vaughan B. In vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications. Int J Nanomedicine. 2019 Mar 27;14:2191-2206. doi: 10.2147/IJN.S198116. eCollection 2019.

PubMed ID: 30988616

Zamani P, Navashenaq JG, Nikpoor AR, Hatamipour M, Oskuee RK, Badiee A, Jaafari MR. MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. J Control Release. 2019 Apr 15;303:223-236. doi: 10.1016/j.jconrel.2019.04.019. [Epub ahead of print]

PubMed ID: 30999007

Leon Chien‐Wei Lin, Chen‐Yu Huang, Bing‐Yu Yao, Jung‐Chen Lin, Anurodh Agrawal, Abdullah Algaissi Bi‐Hung Peng, Yu‐Han Liu, Ping‐Han Huang, Rong‐Huay Juang, Yuan‐Chih Chang, Chien‐Te Tseng Hui‐Wen Chen, Che‐Ming Jack Hu. Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus. Advanced Functional Materials. 2019 April 12. doi: 10.1002/adfm.201807616


Aneja R, Grigoletto A, Nangarlia A, Rashad AA, Wrenn S, Jacobson JM, Pasut G, Chaiken I. Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes. J Pept Sci. 2019 Apr;25(4):e3155. doi: 10.1002/psc.3155. Epub 2019 Feb 27.

PubMed ID: 30809901

Yongchao Zhang, Zhenfen Tian, Xiaotong Zhao, Na Li, Vasil M. Garamus, Peihao Yin, Aihua Zou. Dual-modified bufalin loaded liposomes for enhanced tumor targeting. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2019 June 20;571:72-79. doi: 10.1016/j.colsurfa.2019.03.060


Bohley M, Haunberger A, Goepferich AM. Intracellular availability of poorly soluble drugs from lipid nanocapsules. Eur J Pharm Biopharm. 2019 Mar 6. pii: S0939-6411(18)31530-3. doi: 10.1016/j.ejpb.2019.03.007. [Epub ahead of print]

PubMed ID: 30851353

Farzad N, Barati N, Momtazi-Borojeni AA, Yazdani M, Arab A, Razazan A, Shariat S, Mansourian M, Abbasi A, Saberi Z, Badiee A, Jalali SA, Jaafari MR. P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):665-673. doi: 10.1080/21691401.2019.1576702.

PubMed ID: 30829072

Andey T, Bora-Singhal N, Chellappan SP, Singh M. Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors. Nanomedicine. 2019 Mar 1;18:31-43. doi: 10.1016/j.nano.2019.02.007. [Epub ahead of print]

PubMed ID: 30831275

Marcos-Contreras OA, Brenner JS, Kiseleva RY, Zuluaga-Ramirez V, Greineder CF, Villa CH, Hood ED, Myerson JW, Muro S, Persidsky Y, Muzykantov VR. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain. J Control Release. 2019 Mar 11;301:54-61. doi: 10.1016/j.jconrel.2019.03.008. [Epub ahead of print]

PubMed ID: 30871995

Gao Y, Zheng QC, Xu S, Yuan Y, Cheng X, Jiang S, Kenry, Yu Q, Song Z, Liu B, Li M. Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma. Theranostics. 2019 Feb 12;9(5):1264-1279. doi: 10.7150/thno.29101. eCollection 2019.

PubMed ID: 30867829

Meng Wang, Jun Song, Feifan Zhou, Ashley R. Hoover, Cynthia Murray, Benqing Zhou, Lu Wang, Junle Qu, Wei R. Chen. NIR‐Triggered Phototherapy and Immunotherapy via an Antigen‐Capturing Nanoplatform for Metastatic Cancer Treatment. Advanced Science. 2019 March 13. doi: 10.1002/advs.201802157


Constantinescu CA, Fuior EV, Rebleanu D, Deleanu M, Simion V, Voicu G, Escriou V, Manduteanu I, Simionescu M, Calin M. Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells. Pharmaceutics. 2019 Jan 21;11(1). pii: E47. doi: 10.3390/pharmaceutics11010047.

PubMed ID: 30669699

Wei J, Sun J, Liu Y. Enhanced targeting of prostate cancer-initiating cells by salinomycin-encapsulated lipid-PLGA nanoparticles linked with CD44 antibodies. Oncol Lett. 2019 Apr;17(4):4024-4033. doi: 10.3892/ol.2019.10050. Epub 2019 Feb 19.

PubMed ID: 30930999

Zheng T, Feng H, Liu L, Peng J, Xiao H, Yu T, Zhou Z, Li Y, Zhang Y, Bai X, Zhao S, Shi Y, Chen Y. Enhanced antiproliferative effect of resveratrol in head and neck squamous cell carcinoma using GE11 peptide conjugated liposome. Int J Mol Med. 2019 Feb 13. doi: 10.3892/ijmm.2019.4096. [Epub ahead of print]

PubMed ID: 30816515

Feng C, Zhang H, Chen J, Wang S, Xin Y, Qu Y, Zhang Q, Ji W, Yamashita F, Rui M, Xu X. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer. Int J Pharm. 2019 Apr 5;560:191-204. doi: 10.1016/j.ijpharm.2019.02.009. Epub 2019 Feb 12.

PubMed ID: 30769131

Karamched SR, Nosoudi N, Moreland HE, Chowdhury A, Vyavahare NR. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease. Sci Rep. 2019 Feb 22;9(1):2629. doi: 10.1038/s41598-019-39639-8.

PubMed ID: 30796300

Li X, Xiao H, Lin C, Sun W, Wu T, Wang J, Chen B, Chen X, Cheng D. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomedicine. 2019 Jan 15;14:649-665. doi: 10.2147/IJN.S189819. eCollection 2019.

PubMed ID: 30697048

Kim MW, Jeong HY, Kang SJ, Jeong IH, Choi MJ, You YM, Im CS, Song IH, Lee TS, Lee JS, Lee A, Park YS. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer. Theranostics. 2019 Jan 25;9(3):837-852. doi: 10.7150/thno.30228. eCollection 2019.

PubMed ID: 30809312

Wang S, Wu W, Manghnani P, Xu S, Wang Y, Goh CC, Ng LG, Liu B. Polymerization-Enhanced Two-Photon Photosensitization for Precise Photodynamic Therapy. ACS Nano. 2019 Feb 18. doi: 10.1021/acsnano.8b08398. [Epub ahead of print]

PubMed ID: 30763072

Gui K, Zhang X, Chen F, Ge Z, Zhang S, Qi X, Sun J, Yu Z. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells. Biomed Pharmacother. 2019 Mar;111:751-764. doi: 10.1016/j.biopha.2018.11.118. Epub 2019 Jan 3.

PubMed ID: 30612000

Gaio Paradossi, Letizia Oddo, Barbara Cerroni, Carmit Ben-Harush, Eti Ariel, Francesco Di Meco, Zvi Ram, and Rachel Grossman. In Vivo Toxicity Study of Engineered Lipid Microbubbles in Rodents. ACS Omega, 2019, 4 (3), pp 5526–5533.


Accardo A, Mannucci S, Nicolato E, Vurro F, Diaferia C, Bontempi P, Marzola P, Morelli G. Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells. Drug Deliv Transl Res. 2019 Feb;9(1):215-226. doi: 10.1007/s13346-018-00606-x.

PubMed ID: 30569349

Lin TW, Chien Y, Lin YY, Wang ML, Yarmishyn AA, Yang YP, Hwang DK, Peng CH, Hsu CC, Chen SJ, Chien KH. Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization. Int J Mol Sci. 2019 Jan 9;20(2). pii: E241. doi: 10.3390/ijms20020241.

PubMed ID: 30634448

Li M, Yang Y, Xu C, Wei J, Liu Y, Cun X, Yu Q, Tang X, Yin S, Zhang Z, He Q. Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy. AAPS J. 2019 Jan 11;21(2):18. doi: 10.1208/s12248-018-0289-3.

PubMed ID: 30635795

Liu Y, Chen XG, Yang PP, Qiao ZY, Wang H. Tumor Microenvironmental pH and Enzyme Dual Responsive Polymer-Liposomes for Synergistic Treatment of Cancer Immuno-Chemotherapy. Biomacromolecules. 2019 Feb 11;20(2):882-892. doi: 10.1021/acs.biomac.8b01510. Epub 2019 Jan 18.

PubMed ID: 30621390

Merino M, Contreras A, Casares N, Troconiz IF, Ten Hagen TL, Berraondo P, Zalba S, Garrido MJ. A new immune-nanoplatform for promoting adaptive antitumor immune response. Nanomedicine. 2019 Jan 14;17:13-25. doi: 10.1016/j.nano.2018.12.016. [Epub ahead of print]

PubMed ID: 30654186

Yang F, Zheng Z, Xue X, Zheng L, Qin J, Li H, Zhou Y, Fang G. Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes. Future Oncol. 2019 Jan;15(3):281-295. doi: 10.2217/fon-2018-0295. Epub 2018 Dec 13.

PubMed ID: 30543303

Lin C, Hu Z, Yuan G, Su H, Zeng Y, Guo Z, Zhong F, Jiang K, Songqing H. HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers. J Drug Target. 2018 Nov 27:1-30. doi: 10.1080/1061186X.2018.1552276. [Epub ahead of print]

PubMed ID: 30481072

Chen HH, Liu P, Auger P, Lee SH, Adolfsson O, Rey-Bellet L, Lafrance-Vanasse J, Friedman BA, Pihlgren M, Muhs A, Pfeifer A, Ernst J, Ayalon G, Wildsmith KR, Beach TG, van der Brug MP. Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression.

PubMed ID: 30425303

Amin M, Bagheri M, Mansourian M, Jaafari MR, Ten Hagen TL. Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells. Int J Nanomedicine. 2018 Nov 15;13:7441-7455. doi: 10.2147/IJN.S170274. eCollection 2018.

PubMed ID: 30532532